Skip to main content
Back to News
Primordia Lab raises nearly RMB 300 million for virtual cell research
Funding
2 min read
CN

Primordia Lab raises nearly RMB 300 million for virtual cell research

The AMW Read

The round adds a company-level funding update in virtual cells, while model performance and commercial impact remain unverified.
NoveltySignificance
Healthcare & Bio · Player Map

Primordia Lab raises nearly RMB 300 million for virtual cell research

Shanghai-based Primordia Lab has completed a Pre-A funding round of nearly RMB 300 million, led by Legend Capital. Participating investors included CMC Capital and a JD-affiliated fund, while existing investors also contributed. The company previously raised nearly RMB 100 million across angel and angel-plus rounds. It plans to use the new funding for data collection, an automated platform, model development and hiring.

The round adds capital to the emerging market for biological models that predict how cells respond to interventions. Primordia Lab aims to connect model predictions with laboratory tests and use the resulting data to update its models. This approach could help address gaps in rare cell states or intervention settings that repeated measurements of similar cells may miss. The report describes the company's objectives but provides no independent evidence that its model can reliably predict cell responses.

For investors and builders, the key question is whether each cycle produces useful evidence, rather than simply more measurements. Relevant tests would compare predictions with matched controls and laboratory results across different cell backgrounds and interventions. The report does not disclose customer adoption, commercial revenue or validation results, leaving the platform's practical performance and commercial prospects unverified.

#AI #Biotechnology #VirtualCells #DrugDiscovery #VentureCapital

#Primordia Lab#virtual cells#AI biotechnology#Pre-A funding#related:Legend Capital

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3d agoPrimordia Lab raises nearly RMB 300 million for virtual cell research · THIS ARTICLE
  2. 4d agoIsomorphic Labs raises $5 billion Series C for AI drug discoveryIsomorphic Labs
  3. 0mo agoPathos AI raises $237M to scale Foundry and advance four oncology assetsPathos
  4. 0mo agoWarp Sciences, founded by former OpenAI science lead Kevin Weil, raises $215M to automate drug-chemistry labsWarp Sciences

More news from Primordia Lab (元示科技)

Stay updated with the latest news and announcements from Primordia Lab (元示科技).

View all Primordia Lab (元示科技) news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard